Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G
Complement-associated disorders are caused by the dysregulation and disbalance of the complement system, especially excessive activation. Most drugs that target the complement system are designed to inhibit the complement pathway at either the proximal or terminal levels. The use of a natural comple...
Saved in:
| Main Authors: | Todor Tschongov, Swagata Konwar, Jessika Kleindienst, Paulina Dabrowska-Schlepp, Andreas Busch, Andreas Schaaf, Christoph Schell, Manuel Rogg, Karsten Häffner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1535547/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration
by: Mandy Hector, et al.
Published: (2025-04-01) -
Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy
by: Jill J. Hauer, et al.
Published: (2024-02-01) -
C3 glomerulopathy is highly prevalent in French Polynesia
by: Nelly Candela, et al.
Published: (2024-12-01) -
C3 glomerulopathy triggered by infection-A rare case report
by: Diksha Samsukha, et al.
Published: (2025-08-01) -
The Role of von Willebrand Factor in the Pathogenesis of C3 Glomerulopathy
by: Zixin Hua, et al.
Published: (2025-06-01)